DNA Repair - Cancer Science

What is DNA Repair?

DNA repair is a collection of processes by which a cell identifies and corrects damage to the DNA molecules that encode its genome. These processes are vital for maintaining the integrity of the genetic information and the proper functioning of cellular processes. DNA damage can occur due to environmental factors such as UV light, radiation, and chemicals, or as a result of normal cellular processes like replication.

Why is DNA Repair Important in Cancer?

In the context of cancer, DNA repair mechanisms are crucial because they help prevent the accumulation of genetic mutations that can lead to uncontrolled cell growth and tumorigenesis. Defects in these repair pathways can predispose individuals to cancer by allowing mutations to accumulate in oncogenes and tumor suppressor genes.

Types of DNA Repair Mechanisms

There are several types of DNA repair mechanisms, each specialized for different kinds of damage:
Base Excision Repair (BER): This pathway repairs small, non-helix-distorting base lesions caused by oxidative stress and alkylation.
Nucleotide Excision Repair (NER): NER removes bulky, helix-distorting lesions, such as those caused by UV radiation.
Mismatch Repair (MMR): MMR corrects errors introduced during DNA replication, such as base mismatches and insertion-deletion loops.
Homologous Recombination (HR): HR repairs double-strand breaks accurately using a sister chromatid as a template.
Non-Homologous End Joining (NHEJ): NHEJ repairs double-strand breaks without needing a homologous template, but it is more error-prone than HR.

How Do Defective DNA Repair Mechanisms Lead to Cancer?

Defects in DNA repair pathways can lead to the accumulation of genetic mutations, genomic instability, and ultimately cancer. For example, mutations in the BRCA1 and BRCA2 genes, which are crucial for homologous recombination, are strongly associated with an increased risk of breast and ovarian cancers. Similarly, defects in mismatch repair genes like MLH1 and MSH2 are linked to Lynch syndrome, a hereditary condition that increases the risk of colorectal and other cancers.

Can DNA Repair Pathways Be Targeted for Cancer Therapy?

Yes, targeting defective DNA repair pathways has become a promising approach in cancer therapy. One example is the use of PARP inhibitors in cancers with BRCA1/2 mutations. PARP inhibitors block the repair of single-strand breaks, leading to the accumulation of double-strand breaks. In cells deficient in homologous recombination, such as those with BRCA mutations, this can lead to cell death, thereby selectively targeting cancer cells while sparing normal cells.

What Are the Challenges in Targeting DNA Repair Pathways?

While targeting DNA repair pathways offers significant therapeutic potential, there are challenges. Cancer cells can develop resistance to these therapies through various mechanisms, such as restoring homologous recombination function or upregulating alternative repair pathways. Additionally, because normal cells also rely on DNA repair mechanisms, there can be unintended side effects and toxicity.

Future Directions

Research is ongoing to better understand the complexities of DNA repair pathways and their role in cancer. Advances in genomic sequencing and CRISPR-based technologies are providing new insights into how these pathways can be manipulated for therapeutic benefit. Personalized medicine approaches that tailor treatments based on an individual’s specific genetic defects in DNA repair pathways hold promise for more effective and less toxic cancer therapies.



Relevant Publications

Issue Release: 2024

Partnered Content Networks

Relevant Topics